Medium importance
Uzbekistan · Pharmaceutical Safety Center · 29 July 2026
Additional monitoring of medicines: black triangle labelling
The Uzbekistan Pharmaceutical Safety Center updated material prepared in accordance with Chapter 14 of the national standard O‘z MSt 339:2024 “Good Pharmacovigilance Practices (GVP)”.
Why this matters
The material directly concerns additional monitoring, information in the product instructions and prompt reporting of adverse reactions.
The material directly concerns additional monitoring, information in the product instructions and prompt reporting of adverse reactions.
What is confirmed
- Product instructions for medicines subject to additional monitoring must display a prominent black inverted triangle.
- Unexpected adverse reactions should be reported promptly through the pharmacovigilance system.
- The symbol indicates systematic collection of additional safety information about the medicine.
Official sources
Medicines safety section of the Uzbekistan Pharmaceutical Safety Center
This information is provided for regulatory monitoring and does not replace official regulatory documents or medical advice.